| Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224) |
|---|
| 07/14/2005 | US20050154230 Urea derivatives |
| 07/14/2005 | US20050154056 Inhibitors of HCV NS5B polymerase |
| 07/14/2005 | US20050153981 N1-phenacyl-N4-[2-(benzylamino)-2-oxo-ethyl] piperazine; as neuroprotective agents, in the treatment of ischemic cerebral apoplexy, human cerebral infraction; antiischemic agents for brain disorders; side effect reduction |
| 07/14/2005 | US20050153439 Ecstasy-class derivatives, immunogens, and antibodies and their use in detecting ecstasy-class drugs |
| 07/14/2005 | US20050153363 Polymer arrays |
| 07/14/2005 | US20050153362 Polymer arrays |
| 07/14/2005 | DE10360151A1 New 3-oxo-1-propenyl azo compounds useful as 5-HT receptor antagonists e.g. for treating psychoses, neurological disorders, amyotrophic lateral sclerosis and eating disorders |
| 07/14/2005 | DE102004020443A1 Preparation of vinylene carbonate by dehydrogenation of monohaloethylene carbonate is carried out in ether, preferably methyl tert.-butyl ether, as solvent |
| 07/14/2005 | CA2551567A1 Propofol analogs, process for their preparation, and methods of use |
| 07/13/2005 | EP1553092A1 Aralkyl formyl-alkyl piperazine derivatives and their uses as cerebral nerve protective agent |
| 07/13/2005 | EP1553085A1 Cyclic amine derivatives and their use as drugs |
| 07/13/2005 | EP1551797A1 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
| 07/13/2005 | EP1551795A1 Inhibitors of histone deacetylase |
| 07/13/2005 | EP1161415B1 N-cyanomethylamides as protease inhibitors |
| 07/13/2005 | CN1639125A New inhibitors of histone deacetylase |
| 07/13/2005 | CN1636993A Process for producing novel form of paroxetine hydrochloride anhydrate |
| 07/13/2005 | CN1210251C Substituted nor bornylamion derivatives, method for production thereof, use thereof and medicaments containing said compounds |
| 07/12/2005 | US6916957 Antiinflammatory agents; antihistamines; antiallergens |
| 07/12/2005 | US6916956 Calcium receptor antagonist |
| 07/12/2005 | US6916940 Oxidation, fluorination, desulfurization |
| 07/12/2005 | US6916926 Process for the preparation of (±) 1-3-dioxolanes and the optical resolution thereof |
| 07/12/2005 | US6916837 Such as 2-(6-amidino-2-naphthyloxy)-5-methanesulfonyl-aminobenzoic acid trifluoroacetate; blood coaggulation factor VII inhibitors |
| 07/12/2005 | US6916812 Dietetic agents |
| 07/12/2005 | US6916802 Synthase inhibitors for lowering glycosphingolipid levels; anticancer agents; for treatment of Gaucher's disease |
| 07/07/2005 | WO2005061482A1 Ecstasy haptens and immunogens |
| 07/07/2005 | WO2005061443A2 Benzoyl-substituted phenylalanine amides |
| 07/07/2005 | WO2005060692A2 Biphenyl compounds and methods |
| 07/07/2005 | US20050148801 Chemical intermediates for bronchodilators; 2,2-dimethyl- alpha -nitromethyl-1,3-benzodioxane-6-methanol |
| 07/07/2005 | US20050148800 Low light scattering; near infrared and ultraviolet light transparency; heat, chemical and moisture resistance; flame retardancy; high molecular weight copolymer in combination with perfluorinated olefin monomer; graded refractive index, plastic optical fiber devices |
| 07/07/2005 | US20050148787 Process for the preparation of propylene carbonate |
| 07/07/2005 | US20050148629 Hydroxyamidealkylsulfonamide compounds for anthrax treatment |
| 07/07/2005 | US20050148595 heterocylcyclic amines used for treating or preventing conditions ameliorated by monoamine reuptake such as vasomotor symptoms, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders |
| 07/07/2005 | US20050148027 Very large scale immobilized polymer synthesis |
| 07/07/2005 | CA2548442A1 Benzoyl-substituted phenylalanine amides |
| 07/06/2005 | EP1550655A1 Bicyclic intermediates |
| 07/06/2005 | EP1549631A1 Alkyl glycidol carbonates used as co-surfactants |
| 07/06/2005 | EP1549600A1 Ketones |
| 07/06/2005 | EP1280809B1 Antitumoral ecteinascidin derivatives |
| 07/06/2005 | EP1216225B1 Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 07/05/2005 | CA2220509C Fused polycyclic heterocycle derivatives |
| 06/30/2005 | WO2005058865A2 Assay for entactogens |
| 06/30/2005 | WO2005058864A1 Assay for entactogens |
| 06/30/2005 | WO2005058863A1 Reactive cyclic carbonates and ureas used for modifying biomolecules, polymers, and surfaces |
| 06/30/2005 | WO2005058862A2 Method for producing glycerol carbonate methacrylate |
| 06/30/2005 | WO2005058832A1 Diacylhydrazine derivatives |
| 06/30/2005 | WO2005021526A3 Method for producing fluorinated 1,3-dioxolane compounds, fluorinated 1,3-dioxolane compounds, fluorinated polymers of the fluorinated 1,3-dioxolane compounds, and optical or electrical materials using the polymers |
| 06/30/2005 | US20050143594 Process for preparing resorcinol derivatives |
| 06/30/2005 | US20050143579 for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders |
| 06/30/2005 | US20050143456 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments |
| 06/30/2005 | US20050143426 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 06/30/2005 | US20050143385 Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors |
| 06/30/2005 | US20050143373 Benzodioxole derivatives |
| 06/30/2005 | US20050142155 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 06/30/2005 | DE10355829A1 Alkadienyl-cyclohexenone derivative production, for use as carotenoid intermediate, by catalytic hydrogenation of alkenynyl-cyclohexenone derivative over catalyst containing iron |
| 06/30/2005 | CA2548571A1 Diacylhydrazine derivatives |
| 06/30/2005 | CA2547067A1 Method for producing glycerol carbonate methacrylate |
| 06/29/2005 | EP1546126A1 Process for producing trifluoromethyl-substituted 2-alkoxyacetophenone derivatives |
| 06/29/2005 | EP1546089A2 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 06/29/2005 | EP0901459B1 Calcilytic compounds |
| 06/29/2005 | CN1633426A 1, 3-dihydroxy benzene derivatives and coloring agent containing the same |
| 06/29/2005 | CN1633410A Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps) |
| 06/29/2005 | CN1631886A Process for synthesizing cyclic carbonic ester |
| 06/29/2005 | CN1208329C Aniline derivatives |
| 06/28/2005 | US6911476 Useful for potentiating glutamate receptor function therefore useful for treating a wide variety of conditions, such as psychiatric and neurological disorders |
| 06/28/2005 | CA2168097C Substituted 2-aminotetralins |
| 06/24/2005 | CA2454453A1 Amino ceramide-like compounds and therapeutic methods of use |
| 06/23/2005 | WO2005055941A2 Novel m3 muscarinic acetylcholine receptor antagonists |
| 06/23/2005 | WO2005000406A3 Treatment of amyloid- and epileptogenesis-associated diseases |
| 06/23/2005 | US20050137191 Nitrate esters and their use for mitigating cellular damage |
| 06/23/2005 | CA2549273A1 Novel m3 muscarinic acetylcholine receptor antagonists |
| 06/22/2005 | EP1542981A1 Process for the preparation of 2-amino-4,5,6,7-tetrahydro-6-aminobenzothiaoles from cyclohexanes and cyclohexanones as intermediates |
| 06/22/2005 | EP1542966A1 Aromatic liver x-receptor modulators |
| 06/22/2005 | EP1320523B1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases |
| 06/22/2005 | CN1630555A Hydroxylation of beta-dicarbonyls with zirconium catalysts |
| 06/22/2005 | CN1630515A Compounds active at the glucocorticoid receptor II |
| 06/21/2005 | US6908935 Calcium receptor modulating agents |
| 06/16/2005 | WO2005054429A2 Synthesis of the c1-c6 keto-acid synthon of the epothilones |
| 06/16/2005 | WO2005054313A1 Fluorinated polymers, method for producing the fluorinated compounds and polymers |
| 06/16/2005 | WO2005053610A2 Diamine and iminodiacetic acid hydroxamic acid derivatives |
| 06/16/2005 | US20050130966 Sodium channel modulators |
| 06/16/2005 | US20050130244 for detection of 3,4-methylenedioxyamphetamine (MDA), 3,4-methylenedioxy-methamphetamine (MDMA) anibody production; drug screening; haptens; immunogens |
| 06/16/2005 | US20050130243 For detection of 3,4-methylenedioxyamphetamine (MDA), 3,4-methylenedioxy-methamphetamine (MDMA) anibody production; drug screening; haptens; immunogens; kits |
| 06/16/2005 | US20050130225 Ecstasy haptens and immunogens |
| 06/16/2005 | CA2547356A1 Diamine and iminodiacetic acid hydroxamic acid derivatives |
| 06/15/2005 | EP1541568A1 Reactive cyclic carbonates and ureas for the modification of biomolecules, polymeres and surfaces |
| 06/15/2005 | EP1539697A1 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs |
| 06/15/2005 | EP1539688A2 Novel compounds comprising a thiocarbonyl-sulfanyl group, which can be used for the radical synthesis of alpha-perfluoroalkylamines |
| 06/15/2005 | EP1539683A2 Phenol derivatives and their use as rotamase inhibitors |
| 06/15/2005 | EP1539678A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc-chemokine receptor ligands |
| 06/15/2005 | EP1256576B1 Fused imidazolium derivatives |
| 06/15/2005 | CN1626501A Process for preparing optically active nitro compounds and cyano compounds |
| 06/15/2005 | CN1206228C N-heterocyclic derivatives as NOS inhibitors |
| 06/14/2005 | US6905739 Optically active materials |
| 06/09/2005 | WO2005051939A1 Process for the preparation of propylene carbonate |
| 06/09/2005 | WO2005051373A1 Receptor function regulating agent |
| 06/09/2005 | US20050124656 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps) |
| 06/09/2005 | US20050124654 Compounds and methods of use |
| 06/09/2005 | DE10355830A1 Production of (2-oxo-1,3-dioxolan-4-yl)-methyl methacrylate for use e.g. in adhesives or paint, comprises transesterification of methyl methacrylate with glycerol carbonate using a metal 1,3-diketonate catalyst |
| 06/09/2005 | CA2547430A1 Receptor function regulating agent |
| 06/08/2005 | EP1538150A1 Novel pleuromutilin derivatives |